Columvi▼ and Guidance on Intravenous Administration
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
This article responds to your request for information on Columvi® (glofitamab) and instructions for administration.
Last updated January 06, 2024
Guidance on the administration of Columvi
Prior to administration
Columvi must be administered as an intravenous infusion through a dedicated infusion line as per your local label.
Use of in-line filter is optional according to your local label.
Roche does not have any recommendation regarding a prime or flush with the drug product prior to administration of Columvi infusion bag. However, depending upon your local procedure the infusion set and inline filter may be primed with diluted Columvi solution prior to infusion.[1,2]
Adapt the dose, infusion volume, infusion time and infusion rate according to the treatment day and cycle and if required to the individual clinical situation of the patient.
During admiinstration
Administer the diluted Columvi infusion solution at a constant rate until the Columvi infusion bag is empty. For example, for administering Columvi 2.5 mg dose (25 mL) on Cycle 1 Day 8 with a total infusion time of four hours, administer Columvi at the rate of 6.25 mL/hour until the infusion bag is empty.
Once the Columvi infusion bag is empty, replace the Columvi infusion bag with a 0.9% sodium chloride bag on the same dedicated line. Note that the dedicated infusion line will still contain Columvi solution.[1,2]
Continue the Columvi infusion at 6.25 mL/hour until the Columvi dose solution is completely administered, which is when the total infusion time of 4 hours is reached.[2]
After administration
At the completion of the Columvi infusion, it is recommended to flush the line with 0.9% sodium chloride solution as per your local procedure.[1,2]
References
- Roche Internal Technical Report (Accessed on 10 Dec 2023).
- Roche Internal Technical Report (Accessed on 10 Dec 2023).
Medinfo
Need to contact Roche?
Request Product Information
Request Product Information
Ask us a question and request information about Roche products or services.
Report a potential side effect
Report a potential side effect
If you have experienced potential side effects with a Roche product you can report it here.
Report a potential product defect
Report a potential product defect
If you suspect a potential defect or a Roche product has not met your expectations you can report it here.
Request temperature stability assessment
Request temperature stability assessment
Request an assessment if your product was stored outside the recommended temperature range.
